首页> 美国卫生研究院文献>Journal of Virology >Nuclear Receptor Signaling Inhibits HIV-1 Replication in Macrophages through Multiple trans-Repression Mechanisms
【2h】

Nuclear Receptor Signaling Inhibits HIV-1 Replication in Macrophages through Multiple trans-Repression Mechanisms

机译:核受体信号通过多种反式抑制机制抑制巨噬细胞中的HIV-1复制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Sexually transmitted pathogens activate HIV-1 replication and inflammatory gene expression in macrophages through engagement of Toll-like receptors (TLRs). Ligand-activated nuclear receptor (NR) transcription factors, including glucocorticoid receptor (GR), peroxisome proliferator-activated receptor gamma (PPARγ), and liver X receptor (LXR), are potent inhibitors of TLR-induced inflammatory gene expression. We therefore hypothesized that ligand-activated NRs repress both basal and pathogen-enhanced HIV-1 replication in macrophages by directly repressing HIV-1 transcription and by ameliorating the local proinflammatory response to pathogens. We show that the TLR2 ligand PAM3CSK4 activated virus transcription in macrophages and that NR signaling repressed both basal and TLR-induced HIV-1 transcription. NR ligand treatment repressed HIV-1 expression when added concurrently with TLR ligands and in the presence of cycloheximide, demonstrating that they act independently of new cellular gene expression. We found that treatment with NR ligands inhibited the association of AP-1 and NF-κB subunits, as well as the coactivator CBP, with the long terminal repeat (LTR). We show for the first time that the nuclear corepressor NCoR is bound to HIV-1 LTR in unstimulated macrophages and is released from the LTR after TLR engagement. Treatment with PPARγ and LXR ligands, but not GR ligands, prevented this TLR-induced clearance of NCoR from the LTR. Our data demonstrate that both classical and nonclassical trans-repression mechanisms account for NR-mediated HIV-1 repression. Finally, NR ligand treatment inhibited the potent proinflammatory response induced by PAM3CSK4 that would otherwise activate HIV-1 expression in infected cells. Our findings provide a rationale for studying ligand-activated NRs as modulators of basal and inflammation-induced HIV-1 replication.
机译:性传播的病原体通过参与Toll样受体(TLR)激活巨噬细胞中的HIV-1复制和炎症基因表达。配体激活的核受体(NR)转录因子,包括糖皮质激素受体(GR),过氧化物酶体增殖物激活的受体γ(PPARγ)和肝X受体(LXR),是TLR诱导的炎症基因表达的有效抑制剂。因此,我们假设配体激活的NRs通过直接抑制HIV-1转录并改善对病原体的局部促炎症反应而抑制巨噬细胞中基础和病原体增强的HIV-1复制。我们显示TLR2配体PAM3CSK4激活巨噬细胞中的病毒转录,并且NR信号抑制了基础和TLR诱导的HIV-1转录。 NR配体处理与TLR配体同时添加并且在存在环己酰亚胺的情况下抑制了HIV-1的表达,表明它们独立于新的细胞基因表达起作用。我们发现用NR配体进行的治疗抑制了AP-1和NF-κB亚基以及共激活剂CBP与长末端重复序列(LTR)的结合。我们首次显示核共抑制因子NCoR在未刺激的巨噬细胞中与HIV-1 LTR结合,并在TLR参与后从LTR释放。用PPARγ和LXR配体(而非GR配体)处理可防止TLR诱导NCoR从LTR清除。我们的数据表明,经典和非经典的反式抑制机制都解释了NR介导的HIV-1抑制。最后,NR配体处理抑制了PAM3CSK4诱导的强促炎反应,否则将激活感染细胞中的HIV-1表达。我们的发现为研究配体激活的NRs作为基础和炎症诱导的HIV-1复制的调节剂提供了理论依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号